Clinical Trial Update: Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants [Phase 1, Phase 2]

View source ↗

Summary

This document summarizes a completed Phase 1/2 clinical trial evaluating antioxidants as treatment for newly diagnosed ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Jeanne Drisko, MD, CNS, FACN | Conditions: Ovarian Cancer | Phase 1, Phase 2 | Status: COMPLETED